Malignant hyperthermia

May 20, 2021 by in RHEUMATOLOGY Comments Off on Malignant hyperthermia

• Risk factors for malignant hyperthermia (MH) include a family history of severe hyperthermia or sudden hypermetabolic state during anesthesia with exposure to succinylcholine and/or potent inhalation anesthetics, and ryanodine…

read more

Hypoxic-ischemic encephalopathy

May 20, 2021 by in RHEUMATOLOGY Comments Off on Hypoxic-ischemic encephalopathy

Pearls • Cardiac arrest in pediatric patients is predominantly due to asphyxia. This is in contrast to adults, for whom, despite an increase in asphyxial cardiac arrest related to the…

read more

Tolerance, dependency, and withdrawal

May 20, 2021 by in RHEUMATOLOGY Comments Off on Tolerance, dependency, and withdrawal

• Physical dependency and withdrawal have been documented in all agents used for sedation and analgesia in the pediatric intensive care unit, including benzodiazepines, barbiturates, opioids, dexmedetomidine, propofol, and the…

read more

Neuromuscular blocking agents

May 20, 2021 by in RHEUMATOLOGY Comments Off on Neuromuscular blocking agents

• Through the blockade of skeletal muscle function, neuromuscular blocking agents (NMBAs) cause cessation of respiratory function, mandating airway control and the institution of mechanical ventilation. NMBAs should not be…

read more

Pediatric thoracic trauma

May 20, 2021 by in RHEUMATOLOGY Comments Off on Pediatric thoracic trauma

• Because of increased bone elasticity, rib fractures are uncommon in children and indicate significant traumatic energy delivery, raising concern for injuries of underlying viscera or nonaccidental trauma. • Children…

read more

Renal structure and function

May 20, 2021 by in RHEUMATOLOGY Comments Off on Renal structure and function

Pearls • Development of the definitive human kidney or metanephros begins at 5 weeks’ gestation and is complete by 34 to 36 weeks’ gestation, with an average of 1 million…

read more
Get Clinical Tree app for offline access